Cadence Pharmaceuticals, Inc.

Having finally secured US approval for the post-operative nausea and vomiting (PONV) treatment Barhemsys, the UK's Acacia Pharma Group PLC can put into practice its well-laid plans to get the therap

Big pharma is increasingly reluctant to undertake the development of new antibiotics, but Nabriva Therapeutics PLC 's acquisition of San Diego, CA-based Zavante Therapeutics Inc. and its last-stage

“The Pink Sheet” regularly covers significant deal-making in the biopharmaceutical industry. Here is a summary of the most noteworthy transactions occurring between Feb. 28 and March 12. Endo/Salix

Acquisition has been the name of the game for Mallinckrodt PLC since being spun out from device maker Medtronic Minimally Invasive Therapies in 2013, and its $2.3 billion purchase of Ikaria